Singapore’s cancer screening gap is widening at a critical moment
5 February 2026
Low participation rates, late diagnoses and younger patients point to the urgent need for a rethink. Some recent health statistics paint a troubling picture.
Singapore’s cancer screening gap is widening – at a time when the consequences of inaction are becoming harder to ignore. In his latest commentary, Prof Ravindran Kanesvaran highlights a worrying disconnect and calls for urgent action: despite national screening programmes, participation rates remain low, even as cancer diagnoses rise sharply among younger adults.
Prof Ravindran is also Co-Director, STCC. Through his role, STCC is fostering cross-border partnerships in biobanking and translational cancer research, aligned with key thrusts of RIE2030 strategies, one of which aims to fundamentally transform population health and healthcare, moving beyond treating illness to keeping people healthy for longer through early detection, prevention and targeted interventions.
The full commentary is available on NCCS News and The Straits Times.